Category: Info Sheet
Advancing Lung Cancer Trials with Precision Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths Read Now 
Developing Cutting-edge Treatments for Ovarian Cancer The second most common gynecological cancer in the world is ovarian cancer. Often diagnosed at Read Now 
Early-Phase Oncology Research Expertise Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now 
Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now 
Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now 
Helping to Develop Cell Therapies Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now 
Helping to Bring Antibody Drug Conjugates (ADCs) to Patients Catalyst Oncology is a specialty oncology contract research organization (CRO) devoting time, energy, and capital Read Now 
Ensure Your Oncology Program Is Project Optimus Ready What is Project Optimus? Project Optimus, an initiative from the U.S. Food and Drug Administration Read Now 
Global Regulatory Strategy to Guide Your Oncology Program A well-planned regulatory strategy is critical to the successful launch of your product on a Read Now 
Catalyst Oncology Consulting Catalyst Oncology Consulting is focused solely on the development of new treatments in oncology. Catalyst Read Now